McCormack R T, Nelson R D, Bloomfield C D, Quie P G, Brunning R D
Cancer. 1979 Sep;44(3):920-6. doi: 10.1002/1097-0142(197909)44:3<920::aid-cncr2820440320>3.0.co;2-b.
Neutrophil chemotaxis, phagocytosis, and metabolic stimulation were studied in 25 patients with untreated lymphoreticular malignancies, 8 patients with untreated carcinomas, and 8 patients undergoing therapy for lymphoreticular tumors. Phagocytic activity and metabolic stimulation during phagocytosis were comparable to controls in all patient groups. Slight, but significant, differences were found in chemotactic responsiveness of untreated patient groups when compared to controls. In almost all instances, chemotactic responsiveness reverted to normal in most patients studied after therapy for the malignant process. In patients with intact immunologic function these minor differences in chemotactic responsiveness are probably not sufficient to predispose to infection. However, this defect could be additive, and when present in combination with impaired immunity may contribute to compromised host defense.
对25例未经治疗的淋巴网状恶性肿瘤患者、8例未经治疗的癌症患者以及8例正在接受淋巴网状肿瘤治疗的患者的中性粒细胞趋化性、吞噬作用和代谢刺激进行了研究。所有患者组吞噬过程中的吞噬活性和代谢刺激与对照组相当。与对照组相比,未经治疗的患者组在趋化反应性方面存在轻微但显著的差异。在几乎所有情况下,接受恶性疾病治疗的大多数患者的趋化反应性在研究后恢复正常。在免疫功能完好的患者中,这些趋化反应性的微小差异可能不足以导致感染易感性增加。然而,这种缺陷可能具有累加性,当与免疫功能受损同时存在时,可能会导致宿主防御功能受损。